January 2023 - BioMedWire (BMW)

TuesdayJan 31, 2023 12:14 pm

Research Links Two Natural Deposits to Onset of Macular Degeneration

Macular degeneration is an eye disorder that commonly affects people aged 50 years and older. It occurs when the inner layers of the macula, a region of the retina that provides the eye with a clear vision in the direct line of sight, begin to break down and function less effectively. Although we don’t know precisely what causes macular degeneration, research indicates that it may be due to a combination of environmental factors, including diet and obesity coupled with family genes and age. Close to 20 million Americans aged 40 and older are currently living with some kind of age-related…

MondayJan 30, 2023 11:15 am

MetAlert, Inc. (MLRT) Market for Self-actualized Wellness Grows

Wearable wellness technology innovator MetAlert is revitalizing its brand and increasing its product and services portfolio through M&A and other corporate developments designed to improve the company’s healthcare profile The mortality associated with chronic disease can be ameliorated with the use of wearable devices, along with other healthful practices, and the use of wearable wellness technology is expected to continue at an increasing pace More than 41 million people die of noncommunicable diseases (aka chronic illnesses) each year — 17 million of them before the age of 70, according to the World Health Organization MetAlert’s growing product slate is designed…

MondayJan 30, 2023 11:06 am

Study Determines That How Proteins Move May Influence Brain Tumor Growth

Proteins come in various shapes, making it hard to determine how they move and, in turn, how they function. A study conducted by researchers at the Karolinska Institute has discovered a new target for brain tumors through the use of computer simulations. Laura Orellana, a biophysicist at the institution’s Department of Oncology-Pathology, led the study, which looked into how proteins moved. The study used data from the Protein Data Bank, which comprises decades of information on the 3D structures of different kinds of biological molecules, including proteins. This data is based on experimental techniques such as nuclear magnetic resonance (NMR)…

MondayJan 30, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Reports Promising Prophylactic Results from Preclinical Proof-of-Concept NanoAb COVID-19 Study

BiondVax’s preclinical proof-of-concept study was designed to mimic a real-world situation regarding at-risk groups, including the elderly, people with comorbidities, the immunocompromised, travelers, those attending densely packed social events, and front-line healthcare workers The study shows promising prophylactic results with hamsters receiving BiondVax’s inhaled NanoAb three hours before infection experiencing no significant weight loss over the six-day trial; follows previously reported data showing successful use of NanoAb as COVID-19 therapeutic First-in-human Phase 1/2a clinical trial is planned for later this year Focused on the development, manufacture, and commercialization of innovative NanoAb immunotherapeutic products, BiondVax Pharmaceuticals (NASDAQ: BVXV) recently announced additional…

FridayJan 27, 2023 10:11 am

Study Finds Mucus-Eating Gut Bacteria May Cause Fever Following Cancer Treatment

Cancer treatments often take a huge toll on the patient’s body, causing adverse side effects such as blood clots, nausea and vomiting, hair loss, lymphedema and neutropenia. Neutropenia refers to the loss of neutrophils, which are a type of white blood cell. In severe neutropenia cases, patients develop a fever. New research has linked this fever to bacteria in the gut known as Akkermansia muciniphila (A. muciniphila). The study was led by a team of researchers at the University of Texas MD Anderson Cancer Center. It involved analyzing fecal samples collected from 119 patients who were undergoing stem cell transplantation.…

ThursdayJan 26, 2023 10:21 am

Four Signs Your Child Could Be Autistic

Autism spectrum disorder (ASD) is a developmental disability that usually results in repetitive or restricted behavior as well as problems with social interaction and communication. The Centers for Disease Control and Prevention (CDC) estimates that around 2.21% of adults in America live on the spectrum, with 3.62% of men and 0.86% of women estimated to have the condition. Although ASD can be detected by the time a child is 18 months old, many people do not receive their diagnoses until they are well into their childhood; some individuals aren’t even diagnosed until they become adults. When the condition goes undiagnosed,…

ThursdayJan 26, 2023 9:45 am

MetAlert, Inc. (MLRT) Planned Acquisition of TrakTec LLC Adds Superior Radio Frequency-Based Tracking Technology to Portfolio of Location-Based Solutions

MetAlert recently announced the planned acquisition of TrakTec LLC, a Florida-based leader in location awareness technology for consumer and business applications The acquisition is expected to add several products to MetAlert’s existing suite of products, one of which is an RFID and Bluetooth-enabled tracking technology called SafetyNet(R) The SafetyNet Tracking System comprises the SafetyNet Bracelets that patients wear, and a receiver-antenna combo used by police departments and first responders The Chelmsford Police Department in Massachusetts recently reported it had successfully located a missing senior citizen with dementia because of its participation in the SafetyNet program The department has, over time,…

ThursdayJan 26, 2023 9:00 am

Silo Pharma Inc. (NASDAQ: SILO) Provides Update on UCSF Psylocibin Clinical Trial

SILO recently provided status update on its sponsored clinical trial with UCSF examining psilocybin’s effects on inflammation Targeted patient populations from study may provide support for development and use of psilocybin as a therapeutic to treat inflammatory conditions Data collection from all study groups expected by April 2023 SILO additionally evaluating its ketamine formulation through its partnership agreement with Zylö Therapeutics Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company that fuses traditional medicine with psychedelics, recently provided a progress update on its sponsored clinical trial with the University of California, San Francisco (“UCSF”) examining the effect of psilocybin on…

WednesdayJan 25, 2023 11:11 am

New Study Finds More than 30% of Patients Use Cannabis for Chronic Pain

With more than 30 states allowing some form of cannabis, millions of Americans now have access to the drug in either medical or recreational markets. Over the past decade, research has shown that cannabis has potential as a treatment for conditions such as chronic pain without the side effects typically seen in pharmaceuticals. As a result, dozens of states have launched medical markets that allow patients with qualifying medical conditions to purchase and use legal cannabis for medical purposes. A recent study from the University of Michigan has revealed that slightly more than one-third of adults with chronic pain have…

TuesdayJan 24, 2023 12:17 pm

Toddlers, Infants Risk Severe Outcomes When Faced with Multiple Infections

A study conducted by researchers at Corewell Health East has revealed that toddlers and infants have higher chances of experiencing severe health outcomes in the face of the so-called “tripledemic,” which is comprised of flu, RSV and COVID. Three years after COVID-19 first reared its ugly head, new research found that young patients face the risk of severe health outcomes after being infected by multiple respiratory viruses. The investigators, led by Dr. Amit Bahl, found that although omicron cases made up the bulk of hospital admissions for those between the ages of 0 and 17, they weren’t as likely to…